# TherapeuticsMD, Inc.: Form 10-K/A for the period ended Dec 31, 2022

- Company: [TherapeuticsMD, Inc.](/companies/txmd.md) (CIK 25743)
- Form: 10-K/A
- Filed: 2023-05-01
- Accepted by EDGAR: May 1, 2023, 17:03 ET
- Period: 2022-12-31
- Accession: 0001193125-23-130656
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/25743/000119312523130656/d497484d10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/25743/000119312523130656/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/25743/000119312523130656/d497484d10ka.htm

Filed May 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-130656. Last ingested by Listed: Oct 24, 2026, 14:52 ET. No prices; not investment advice.